Nanexa
1.51
SEK
+3.42 %
NANEXA
First North Stockholm
Biotechnology & Pharmaceuticals
Health Care
Less than 1K followers
+3.42%
-36.29%
-30.09%
+2.37%
+53.77%
+41.12%
-62.72%
-79.94%
-81.54%
Nanexa is a drug delivery company with a proprietary platform that is used for the formulation of injectable depot drugs that create a supply of drugs to the blood. The PharmaShell process is based on ALD (Atomic Layer Deposition) technology, which encloses pharmaceutical particles with a thin shell and creates opportunities for pharmaceutical companies to develop new products. Nanexa has cooperation with several pharmaceutical companies, mainly around the Nordic market.
Read moreMarket cap
225.29M SEK
Turnover
324.42K SEK
Revenue
29.33M
EBIT %
-261.27 %
P/E
-
Dividend yield-%
-
Financial calendar
13.2
2025
Extraordinary general meeting '24
19.2
2025
Annual report '24
ShowingAll content types
Emergers: Equity Research | NANEXA: Financing secured into 2026 to drive NEX-22 development
Notice of extraordinary general meeting in Nanexa AB
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools